Why gut bacteria are uniquely matched to each host
The modes and genomics of gut bacterial specificity to host species
['FUNDING_OTHER'] · PRINCETON UNIVERSITY · NIH-11260331
Scientists are figuring out how gut bacteria become specially adapted to different mammal hosts, which could help us understand links between microbes and health.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | PRINCETON UNIVERSITY (nih funded) |
| Locations | 1 site (Princeton, UNITED STATES) |
| Trial ID | NIH-11260331 on ClinicalTrials.gov |
What this research studies
If you're following this work, researchers are comparing gut microbes from different mammal species to learn why some bacteria only thrive in certain hosts. They will use genomic sequencing of bacterial strains and controlled experiments in germ-free mice to test roles for innate immunity, bacteria-bacteria interactions, and transmission. Lab co-culture experiments and genetic analyses will search for bacterial genes and host factors that drive host specificity. Most work is done in animal and lab models at Princeton, with the aim of shedding light on human gut-microbiome relationships.
Who could benefit from this research
Good fit: Ideal candidates for future related studies would be people interested in gut microbiome research or eligible to provide stool samples for microbiome profiling or clinical follow-up.
Not a fit: People seeking immediate treatments or those with conditions unrelated to the gut microbiome are unlikely to see direct benefits from this basic research right away.
Why it matters
Potential benefit: If successful, this research could reveal mechanisms by which gut microbes affect immune function and growth and point toward new microbiome-based therapies.
How similar studies have performed: Previous sequencing and germ-free mouse experiments have shown host-specific microbiomes and effects on immunity and growth, but the precise mechanisms targeted here remain largely unproven.
Where this research is happening
Princeton, UNITED STATES
- PRINCETON UNIVERSITY — Princeton, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: MOELLER, ANDREW — PRINCETON UNIVERSITY
- Study coordinator: MOELLER, ANDREW
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancers, Disease, Disorder